Bilateral synchronous breast cancer: A population-based study of characteristics, method of detection, and survival

Surgery

Volumn 133, Issue 4, 2003, Pages 383-389

  Polednak, Anthony P ^a,b  

^a Department of Public Health ^*  (United States)

^b Department of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PALPATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS;

EID: 0037396653     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.110     Document Type: Article

References (22)

1. Hungness ES, Safa M, Shaunghnessey EA, Aron BS, Gazder PA, Hawkins HH, et al. Bilateral synchronous breast cancer: modes of detection and comparison of histologic features between the 2 breasts. Surgery 2000;128:702-7.
2. Robinson E, Rennert G, Rennert HS, Neugut AI. Survival in bilateral breast cancer. Cancer 1993;71:172-6.
3. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK, editors. SEER cancer statistics review, 1973-1996. NIH Publication No. 99-2789. Bethesda (MD): National Cancer Institute; 1999.
4. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the NCI. Cancer 1995;76:2343-50.
5. Shambaugh E. Stat bite: accuracy of SEER data. J Natl Cancer Inst 1991;83:1369.
6. Fritz A. The SEER program's commitment to data quality. J Registry Management 2001;28:35-40.
7. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomark Prey 1999;8:855-61.
8. Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 1999;25:584-9.
9. Haenszel W, Loveland DB, Sirken MG. Lung cancer mortality as related to residence and smoking histories. I. White males. J Natl Cancer Inst 1962;28:947-1001.
10. Norusis MJ. SPSS advanced statistics 6.1. Chicago (Ill): SPSS Inc; 1994.
11. Gollamudi SV, Gelman RS, Peior G, Schneider LJ, Schnitt SJ, Recht A, et al. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer 1997;79:1362-9.
12. Lees JSY, Grant CS, Donohue JH, Crotty TB, Harmsen WS, Ilstrup DM. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 1995;118:640-8.
13. Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment. Ann Surg Oncol 1997;4:198-202.
14. Steinman D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, et al. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br J Cancer 2001;85:850-8.
15. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546-54.
16. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Clinical oncology. 2nd ed. New York: Churchill Livingstl; 2000.
17. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI. The consensus conference on the treatment of in situ carcinoma of the breast, April 22-25, 1999. Hum Pathol 2000;31:131-9.
18. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400-18.
19. DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
20. Berg JW, Hutter RVP. Breast cancer. Cancer 1995;75:257-69.
21. Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 2000;283;617-24.
22. Skinner KA, Silberman H, Sposto R, Silverstein MJ. Palpable breast cancers are inherendy different from nonpalpable breast cancers. Ann Surg Oncol 2001;8:705-10.